Glioblastoma
Glioblastoma is a fast-growing and aggressive type of brain cancer that arises from glial cells, often leading to severe neurological symptoms and a poor prognosis.
Glioblastoma: Dendritic Cell Immunotherapy Study
We are evaluating a new immune therapy for patients with glioblastoma to see if it improves survival and quality of life compared to standard treatments.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 70 years old?
- Are you currently pregnant or breastfeeding?
- Have you had any other cancers besides glioblastoma?
- Do you have any serious heart problems or other major medical illnesses?
- Are you taking glucocorticoids like Prednisone or Dexamethasone?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Autologous Cancer Stem Cell mRNA Transfected Dendritic Cells
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Oslo University Hospital HF
Department of Neurosurgery
Oslo, Norway
Sponsor: Oslo University Hospital HF
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.